Psychedelic Therapy—A New Paradigm of Care for Mental Health
JAMA August 31, 2023 DOI: 10.1001/jama.2023.12900 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Addiction Anxiety Psychedelic-assisted therapy |
| Keywords | Mental health Eating disorders Depression economics Posttraumatic stress Psychotherapist |
| Citations | 33 |
| Key findings | Clinicians and researchers are increasingly interested in the therapeutic potential of psychedelic drugs for several mental health disorders. |
Abstract
An increasing number of clinicians and researchers have become interested in the potential of psychedelic drugs for the treatment of mental health disorders, including depression, anxiety, posttraumatic stress disorder, eating disorders, and addictions.1,2
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cited by 26
- Scoping Review: The Role of Psychedelics in the Management of Chronic Pain Journal of Pain Research March 1, 2024
- Psychedelics and the treatment of eating disorders: considerations for future research and practice. Journal of Eating Disorders October 22, 2024
- Psychedelic therapy - refining the claim of a paradigm shift. International Review of Psychiatry December 1, 2024
- Fragile promise of psychedelics in psychiatry BMJ November 19, 2024
- The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance Future Humanities December 26, 2024
and 21 more in the library
Cites 4
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Single-Dose Psilocybin Treatment for Major Depressive Disorder JAMA August 31, 2023
- The Current Status of Psychedelics in Psychiatry. JAMA Psychiatry February 1, 2021